Profiles for companies starting with 'a'
✉ Email this page to a colleague
Drugs and US Patents for a
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Altaire Pharms Inc | NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE | naphazoline hydrochloride; pheniramine maleate | SOLUTION/DROPS;OPHTHALMIC | 078208-001 | Sep 27, 2010 | OTC | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Astrazeneca | LYNPARZA | olaparib | TABLET;ORAL | 208558-001 | Aug 17, 2017 | RX | Yes | No | 12,144,810 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Acs Dobfar | CEFAZOLIN SODIUM | cefazolin sodium | INJECTABLE;INJECTION | 065306-001 | Oct 22, 2008 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Azurity | VIVIMUSTA | bendamustine hydrochloride | SOLUTION;INTRAVENOUS | 212209-001 | Dec 7, 2022 | RX | Yes | Yes | 12,208,086 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
